Short communication · 29 Dec 2025
Conference abstractPublished 6 Dec 2018
Study of imipenem/cilastatin resistance among hospitalized patients in Sana’a, Yemen
Sanaa University, Yemen
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Carbapenems are considered as the most effective drugs against most pathogens. Imipenem/cilastatin is the most marketed carbapenem in Yemen. Carbapenem resistance is a major and an on-going public health problem globally. It occurs mainly among Gramnegative bacteria. Objectives: The present study was designed to determine the prevalence of imipenem/cilastatin resistance among hospitalized patients at a local hospital in Sana'a, Yemen. Methods: The study was performed at a local hospital in Sanaâ??a, Yemen. The records were taken from the Microbiology Department for hospitalized patients. Imipenem/cilastatin susceptibility samples were collected from August, 2017 to May, 2018. The imipenem/cilastatin susceptibility was studied against several pathogens. Results: Out of 863 study samples, 541 (62.7%) were imipenem/cilastatin sensitive isolates and only 25.5% of samples were resistant. The Escherichia coli isolates were observed in 24.7% of samples, followed by Acinetobacter species (17.4%). Thirty-seven and five tenths percent of total imipenem/cilastatin sensitive isolates (541) were Escherichia coli. In addition, 95.3% (203/213) of Escherichia coli isolates were imipenem/cilastatin sensitive. However, the Acinetobacter species had higher imipenem/cilastatin resistance than other pathogens (60.45%). Moreover, 88.7% (133/150) of Acinetobacter species isolates were imipenem/cilastatin resistant. Eighty-one and three tenths percent (65/80) of Klebsiella pneumoniae isolates were imipenem/cilastatin sensitive and 33.7% (32/96) of Pseudomonas aeruginosa were imipenem/cilastatin resistant. In the present study, 31.1% (n=168/541) of imipenem/cilastatin sensitive isolates were from blood cultures, followed by sputum cultures (22.6%; 122/541). However, 65.5% (144/220) of sputum culture isolates were imipenem/cilastatin resistant. Conclusion: Imipenem/cilastatin resistance of multidrug-resistant bacteria is slowly increasing in Yemen and possesses a significant challenge to public health. Surveillance to closely monitor trends as well as infection control and antibiotic stewardship activities are necessary to preserve treatment options. A more careful monitoring for use of broad-spectrum antibiotics should be instituted
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Immunome Research.
Commentary · 27 Dec 2025
Stress-Induced Remodeling of Immune Cell Phenotypes
Perspective · 26 Dec 2025
Immune System Dysregulation in Complex Multisystem Disorders
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalImmunome Research
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Ali Alkaf”
